Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO:2503) and Mitsui Norin Co., Ltd. (Mitsui Norin) are developing a ...
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial in patients with relapsed/refractory ...
Kirin Holdings Company, Ltd. (Kirin Holdings) (TOKYO: 2503) and Kirin Beverage Company, Ltd. (Kirin Beverage) have been ...
Kirin Holdings Company, Limited (Kirin Holdings) (TOKYO:2503) and Mitsui Norin Co., Ltd. (Mitsui Norin) are developing a human rights due diligence initiative targeting tea plantations in Sri ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--Siolta Therapeutics, a leader in the development of live biotherapeutic products (LBPs), and Cowellnex Co. Ltd, a Kirin and Kyowa Kirin joint investment ...
today announced the continuation and expansion of its collaboration with Kyowa Kirin Co., Ltd. (Kyowa Kirin), a Japan-based global specialty pharmaceutical company. The enhanced partnership provides ...